An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, further providing for coverage for biomarker testing.

Summary

The bill updates the state's 1921 Insurance Company Law to include coverage for biomarker testing within casualty insurance policies. It affects insurance companies that sell casualty coverage and the policyholders who would receive the testing benefits. Expanding coverage aims to improve access to advanced diagnostic tools for insured individuals.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share